Total trials
178
Active
24
Phase 3
9
Total enrollment
65,901
Pipeline matrix
Showing 8 of 8 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Olanzapine | — | — | — | — | 3 | ||
| Candesartan | — | — | — | — | — | 1 | |
| Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone | — | — | — | — | — | 1 | |
| Resveratrol | — | — | — | — | — | 1 | |
| Antifungal treatment | — | — | — | — | — | 1 | |
| NMD; 0.4mg sub-lingual nitroglycerin spray | — | — | — | — | — | 1 | |
| Genetic Testing for hematological malignancies | — | — | — | — | — | 1 | |
| Bosentan | — | — | — | — | — | 1 |
Next readouts
- 2025-12
- 2025-12
- 2026-12
- 2027-01-01
- 2027-05-01
- 2027-10
- 2027-11-01
- 2029-02
Top conditions
- Cardiovascular Diseases10
- Hypertension10
- Obesity10
- Constipation9
- Fecal Incontinence5
- Blood Pressure5
- Heart Diseases5
- Cystic Fibrosis4
Frequently asked questions about Augusta University
- How many clinical trials does Augusta University have on ClinicalTrials.gov?
- Augusta University is listed as the lead sponsor on 178 clinical trials in ClinicalTrials.gov, 24 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Augusta University's trials are in Phase 3?
- 9 of Augusta University's trials are in Phase 3, spread across 8 active drug programs.
- What therapeutic areas does Augusta University focus on?
- Augusta University's most-studied conditions on ClinicalTrials.gov are Cardiovascular Diseases, Hypertension, Obesity, Constipation, Fecal Incontinence.
- When are Augusta University's next clinical trial readouts?
- Augusta University has 8 upcoming primary-completion readouts tracked here; the soonest is “Adiposity and Endothelin Receptor Function”, expected around 2025-12.